AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654,103 | +6.7% | 84,183 | +32.9% | 0.00% | – |
| Q2 2023 | $613,229 | -45.8% | 63,350 | -38.7% | 0.00% | – |
| Q1 2023 | $1,132,224 | -35.9% | 103,305 | -74.7% | 0.00% | – |
| Q4 2022 | $1,765,696 | -9.4% | 408,726 | +57.7% | 0.00% | – |
| Q3 2022 | $1,949,000 | +52.5% | 259,217 | +103.9% | 0.00% | – |
| Q2 2022 | $1,278,000 | +87.9% | 127,134 | +131.3% | 0.00% | – |
| Q1 2022 | $680,000 | -57.0% | 54,972 | -20.6% | 0.00% | – |
| Q4 2021 | $1,582,000 | +62.6% | 69,202 | +57.5% | 0.00% | – |
| Q3 2021 | $973,000 | +30.4% | 43,945 | -23.7% | 0.00% | – |
| Q2 2021 | $746,000 | -19.2% | 57,562 | -19.0% | 0.00% | – |
| Q1 2021 | $923,000 | -34.7% | 71,084 | -30.4% | 0.00% | – |
| Q4 2020 | $1,413,000 | +238.0% | 102,138 | +260.9% | 0.00% | – |
| Q3 2020 | $418,000 | +30.6% | 28,300 | +43.8% | 0.00% | – |
| Q2 2020 | $320,000 | +4.6% | 19,683 | -6.4% | 0.00% | – |
| Q1 2020 | $306,000 | -76.9% | 21,029 | -67.8% | 0.00% | – |
| Q4 2019 | $1,322,000 | +132100.0% | 65,250 | +49709.2% | 0.00% | – |
| Q3 2019 | $1,000 | -95.7% | 131 | -96.1% | 0.00% | – |
| Q2 2019 | $23,000 | -74.2% | 3,389 | -75.6% | 0.00% | – |
| Q1 2019 | $89,000 | -57.6% | 13,872 | -54.8% | 0.00% | – |
| Q4 2018 | $210,000 | +6900.0% | 30,713 | +8600.6% | 0.00% | – |
| Q3 2018 | $3,000 | -75.0% | 353 | -83.8% | 0.00% | – |
| Q2 2018 | $12,000 | +100.0% | 2,182 | +80.6% | 0.00% | – |
| Q1 2018 | $6,000 | -85.7% | 1,208 | -86.7% | 0.00% | – |
| Q4 2017 | $42,000 | +4100.0% | 9,100 | +9000.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 100 | -66.7% | 0.00% | – |
| Q2 2017 | $2,000 | -85.7% | 300 | -84.5% | 0.00% | – |
| Q1 2017 | $14,000 | – | 1,936 | +1836.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 100 | -90.0% | 0.00% | – |
| Q1 2016 | $3,000 | +200.0% | 1,000 | +150.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |